Librela

Librela

What is Librela?

Librela is an FDA approved monoclonal antibody that targets NGF (nerve growth factor) to decrease pain for dogs with arthritis. NGF is upregulated in arthritic joints and binds to nerves to send increased pain signals to the body. With Librela, the NGF is bound by the monoclonal antibody, which prevents the increased pain signals. The monoclonal antibody is then expected to be broken down by the body into amino acids and peptides similar to other dog antibodies.

More About Librela

Let's Get Your Pet Back On Their Paws!

PREFER TO REACH US BY PHONE?

Call us at (720) 639-3924

Skip to content